Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...

Enhanced Elimination of Poison

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...

Bioequivalence of Drugs: Drugs with Multiple Indications

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Global groundwater contamination by geogenic fluoride.

Environmental geochemistry and health·2026

Same author

A five-year dive in the realm of crystal engineering with water-soluble vitamins in addressing biopharmaceutical bottlenecks.

Talanta·2026

Same author

Artificial Intelligence in Health Care: Clinical Opportunities, Validation Trends, and Implementation Challenges (2020-2025).

Journal for healthcare quality : official publication of the National Association for Healthcare Quality·2026

Same author

On Double Cyclic Codes over Finite Chain Rings for DNA Computing.

Entropy (Basel, Switzerland)·2025

Same author

Adjunctive zinc supplementation with methotrexate improves therapeutic outcomes in an animal model of arthritis.

Inflammopharmacology·2025

Same author

Profiling HIV1-host protein-protein interaction networks in patient-derived exosome proteins: impact on pathophysiology and innate immune pathways.

Virology journal·2025

Search research articles

Related Experiment Video

Updated: Nov 18, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Emerging Multi-Drug Eutectics: Opportunities and Challenges.

Jamshed Haneef¹, Shakir Ali², Renu Chadha³

¹Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110 062, India. jamshedhaneef@jamiahamdard.ac.in.

AAPS Pharmscitech

|February 8, 2021

Summary

Multidrug eutectics (MDE) offer a novel approach to overcome challenges in fixed-dose combination therapies. These solid forms enhance drug solubility and dissolution, improving patient compliance and therapeutic outcomes.

Keywords:

crystal engineering eutectic mixtures fixed-dose combination non-covalent derivative thermal analysis

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Nov 18, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Area of Science:

Pharmaceutical Science
Materials Science
Drug Delivery

Background:

Complex diseases necessitate improved combination therapies for better patient compliance and efficacy.
Existing fixed-dose combination drugs face challenges in biopharmaceutical properties.
Multidrug eutectics (MDE) present a promising strategy to address these limitations.

Purpose of the Study:

To provide a comprehensive review of multidrug eutectics (MDE) for combination therapy.
To discuss the design, drug selection, characterization, and therapeutic potential of MDE.
To outline the future prospects of MDE in advancing combination drug treatments.

Main Methods:

Review of existing literature on multidrug eutectics.
Analysis of MDE design principles and rational drug selection criteria.
Discussion of characterization techniques for MDE.
Evaluation of therapeutic efficacy and biopharmaceutical improvements offered by MDE.

Main Results:

MDE are multicomponent solid forms with a lower melting point than individual components.
Non-covalent linking in MDE enhances solubility, dissolution, and mechanical properties.
MDE demonstrate potential for synergistic therapeutic action and improved patient compliance.
Various characterization tools are available to assess MDE properties.

Conclusions:

Multidrug eutectics represent an innovative strategy for developing advanced fixed-dose combination therapies.
MDE offer significant improvements in biopharmaceutical attributes and therapeutic efficacy.
Further research into MDE design and application holds great promise for future combination treatments.